Sustained Virologic Response MeSH Descriptor Data 2024

MeSH Heading: Sustained Virologic Response
Tree Number(s): E01.789.800.570; N04.761.559.590.800.665; N05.715.360.575.575.800.665
Unique ID: D000072230
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000072230
Scope Note: The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.
Entry Term(s): Sustained Viral Suppression
Previous Indexing: Antiviral Agents/therapeutic use (1999-2016); Drug Therapy, Combination (1999-2016); Treatment Outcome (1999-2016)
Public MeSH Note: 2017
History Note: 2017
Date Established: 2017/01/01
Date of Entry: 2016/07/08
Revision Date: 2016/05/27

No Qualifiers

Diagnosis [E01]
- Prognosis [E01.789]
  - Treatment Outcome [E01.789.800]

Health Services Administration [N04]
- Quality of Health Care [N04.761]
  - Outcome and Process Assessment, Health Care [N04.761.559]
    - Outcome Assessment, Health Care [N04.761.559.590]
      - Treatment Outcome [N04.761.559.590.800]
        
        Disease-Free Survival [N04.761.559.590.800.190]
        
        Early Termination of Clinical Trials [N04.761.559.590.800.379]
        
        Pathologic Complete Response [N04.761.559.590.800.427]
        
        Progression-Free Survival [N04.761.559.590.800.474]
        
        Response Evaluation Criteria in Solid Tumors [N04.761.559.590.800.569]
        
        Sustained Virologic Response [N04.761.559.590.800.665]
        
        Therapeutic Index [N04.761.559.590.800.713]
        
        Treatment Failure [N04.761.559.590.800.760]

Health Care Quality, Access, and Evaluation [N05]
- Quality of Health Care [N05.715]
  - Health Care Evaluation Mechanisms [N05.715.360]
    - Outcome and Process Assessment, Health Care [N05.715.360.575]
      - Outcome Assessment, Health Care [N05.715.360.575.575]
        
        Treatment Outcome [N05.715.360.575.575.800]
        
        Disease-Free Survival [N05.715.360.575.575.800.190]
        
        Early Termination of Clinical Trials [N05.715.360.575.575.800.379]
        
        Pathologic Complete Response [N05.715.360.575.575.800.427]
        
        Progression-Free Survival [N05.715.360.575.575.800.474]
        
        Response Evaluation Criteria in Solid Tumors [N05.715.360.575.575.800.569]
        
        Sustained Virologic Response [N05.715.360.575.575.800.665]
        
        Therapeutic Index [N05.715.360.575.575.800.713]
        
        Treatment Effect Heterogeneity [N05.715.360.575.575.800.737]
        
        Treatment Failure [N05.715.360.575.575.800.760]

Sustained Virologic Response Preferred

page delivered in 0.164s